Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively ​by healthcare research firm 3 Axis Advisors.